RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.95B
1-Year Est. Return
81.42%
This Fund
S&P 500
1 Year Est. Return
+81.42%
AUM
$1.95B
AUM Growth
+$238M
(+14%)
Holding
110
Top Buys
| 1 | +$13.8M | |
| 2 | +$8.05M | |
| 3 | +$6.64M | |
| 4 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$6.45M |
| 5 |
Immunome
IMNM
|
+$6.1M |
Top Sells
| 1 | +$56.2M | |
| 2 | +$33.8M | |
| 3 | +$29.7M | |
| 4 |
Insmed
INSM
|
+$12M |
| 5 |
MREO
Mereo BioPharma
MREO
|
+$9.42M |
Sector Composition
| 1 | Healthcare | 98.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tenet Healthcare
THC
$20.8B
| $24.8M | 1.27% |
125,000
|
|
||
27
DexCom
DXCM
$28.3B
| $23.1M | 1.18% |
347,300
+30,400
|
|
||
28
Agios Pharmaceuticals
AGIO
$1.77B
| $21.8M | 1.12% |
799,163
-159,379
|
|
||
29
Tarsus Pharmaceuticals
TARS
$3.21B
| $21.3M | 1.09% |
260,344
-28,000
|
|
||
30
Compass Therapeutics
CMPX
$1B
| $21.1M | 1.08% |
3,927,202
-547,500
|
|
||
31
NewAmsterdam Pharma
NAMS
$4.08B
| $19.5M | 1% |
557,194
-38,735
|
|
||
32
Azenta
AZTA
$1.24B
| $18.9M | 0.97% |
569,100
+28,700
|
|
||
33
Celldex Therapeutics
CLDX
$2B
| $18.8M | 0.97% |
692,538
-29,000
|
|
||
|
CAI
34
Caris Life Sciences
CAI
$5.68B
| $18.5M | 0.95% |
687,500
-106,151
|
|
||
|
ZBIO
35
Zenas BioPharma
ZBIO
$1.41B
| $18.2M | 0.94% |
502,077
-78,600
|
|
||
36
Dyne Therapeutics
DYN
$2.57B
| $17.9M | 0.92% |
912,955
+88,894
|
|
||
37
Neurocrine Biosciences
NBIX
$13.3B
| $17.8M | 0.91% |
125,500
+35,750
|
|
||
38
Pharvaris
PHVS
$1.84B
| $17.3M | 0.89% |
623,402
|
|
||
39
Mineralys Therapeutics
MLYS
$2.32B
| $15.5M | 0.8% |
427,596
+19,283
|
|
||
40
Phreesia
PHR
$743M
| $14.8M | 0.76% |
876,600
+127,484
|
|
||
41
Zai Lab
ZLAB
$2.15B
| $14.3M | 0.73% |
811,546
+20,353
|
|
||
42
Danaher
DHR
$149B
| $14.1M | 0.72% |
61,500
|
|
||
43
UnitedHealth
UNH
$266B
| $13.5M | 0.69% |
+40,800
|
|
||
44
Ardelyx
ARDX
$1.59B
| $13.4M | 0.69% |
2,299,473
+13,200
|
|
||
45
Aclaris Therapeutics
ACRS
$311M
| $13.4M | 0.69% |
4,453,741
-155,568
|
|
||
46
Summit Therapeutics
SMMT
$12.4B
| $12.4M | 0.64% |
710,000
|
|
||
47
Enliven Therapeutics
ELVN
$1.76B
| $12.3M | 0.63% |
798,405
+112,298
|
|
||
48
Inspire Medical Systems
INSP
$1.84B
| $12.1M | 0.62% |
131,000
+20,500
|
|
||
|
OMDA
49
Omada Health Inc
OMDA
$711M
| $11.7M | 0.6% |
740,000
-179,950
|
|
||
50
Soleno Therapeutics
SLNO
$2.1B
| $11.4M | 0.59% |
247,053
+92,525
|
|